Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Gilead Sciences, Inc.
  6. Company
    GILD

GILEAD SCIENCES, INC.

(GILD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Gilead Sciences, Inc.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Number of employees : 13 600 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Innovative Medicines22,449100.6%24,689100.2% +9.98%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
United States16,64574.6%18,21773.9% +9.44%
Europe3,81117.1%4,13516.8% +8.5%
Other International1,9938.9%2,3379.5% +17.26%
Managers
NameAgeSinceTitle
Daniel O'Day552019Chairman & Chief Executive Officer
Andrew Dickinson502019Chief Financial Officer
Merdad Parsey562019Chief Medical Officer
Brett Pletcher53-Secretary, Chief Compliance Officer & Executive VP
Richard J. Whitley, Dr.732008Independent Director
Kevin E. Lofton652009Independent Director
Per Wold-Olsen732010Independent Director
Kelly A. Kramer522016Independent Director
Jacqueline K. Barton, Dr.672018Independent Director
Harish M. Manwani662018Independent Director
Members of the board
NameAgeSinceTitle
Daniel O'Day552019Chairman & Chief Executive Officer
Richard J. Whitley, Dr.732008Independent Director
Kevin E. Lofton652009Independent Director
Per Wold-Olsen732010Independent Director
Kelly A. Kramer522016Independent Director
Jacqueline K. Barton, Dr.672018Independent Director
Harish M. Manwani662018Independent Director
Sandra J. Horning, Dr.712020Independent Director
Javier Rodriguez492020Independent Director
Anthony Welters652020Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,259,056,043 1,252,149,307 99.5% 0 0.0% 99.5%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 121,672,399 9.68%
The Vanguard Group, Inc. 97,128,178 7.73%
Capital Research & Management Co. 64,780,000 5.16%
SSgA Funds Management, Inc. 55,206,559 4.39%
Capital Research & Management Co. (International Investors) 46,548,996 3.70%
Capital Research & Management Co. (World Investors) 38,534,588 3.07%
BlackRock Fund Advisors 31,581,841 2.51%
Geode Capital Management LLC 20,078,920 1.60%
Dodge & Cox 17,107,888 1.36%
Northern Trust Investments, Inc.(Investment Management) 15,243,829 1.21%
Holdings
NameEquities%Valuation
Galapagos NV (GLPG) 16,707,47725.5%1,298,352,072 USD
Arcus Biosciences, Inc. (RCUS) 13,913,02919.6%390,677,854 USD
Allogene Therapeutics, Inc. (ALLO) 7,486,6895.32%264,280,122 USD
Jounce Therapeutics, Inc. (JNCE) 5,539,72711.0%56,892,996 USD
Agenus Inc. (AGEN) 11,111,1115.43%30,222,222 USD
HOOKIPA Pharma Inc. (HOOK) 2,092,7998.06%28,148,147 USD
Sierra Oncology, Inc. (SRRA) 348,0172.99%5,996,333 USD
Markets and indexes
-
- Nasdaq Global Select Market
- Nasdaq 100 / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  GILD:US
- Reuters Code :  GILD.O
- Datastream Code :  @GILD
Company contact information
Gilead Sciences, Inc.
333 Lakeside Drive
CA 94404 San Mateo, California


Phone : +1 650 574 3000
Fax : +1 650 578 9264
web site : http://www.gilead.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Gilead Sciences, Inc.
Analysis
Focus: Money, talent flowing into mRNA sector after COVID-19 success
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
GILEAD SCIENCES, INC.11.00%81 134
WUXI APPTEC CO., LTD.16.04%57 216
VERTEX PHARMACEUTICALS-9.67%55 784
REGENERON PHARMACEUTICALS1.80%50 920
BIONTECH SE115.62%41 745
BEIGENE, LTD.36.04%29 788
GENMAB A/S-7.88%24 085
ARGENX SE-0.83%14 853
HUALAN BIOLOGICAL ENGINEERING INC.5.99%12 626
NEUROCRINE BIOSCIENCES, INC.1.93%9 234
FATE THERAPEUTICS, INC.1.28%8 687
MIRATI THERAPEUTICS, INC.-26.96%7 852
ARROWHEAD PHARMACEUTICALS, INC.-2.88%7 735
EXELIXIS, INC.23.32%7 712
ULTRAGENYX PHARMACEUTICAL INC.-17.03%7 589
ACCELERON PHARMA INC.-0.77%7 557
DENALI THERAPEUTICS INC.-24.50%7 437
HALOZYME THERAPEUTICS, INC.19.46%7 375
ASCENDIS PHARMA A/S-17.09%7 337
GW PHARMACEUTICALS PLC89.75%6 898
BIOCON LIMITED-14.46%6 325
Connections : Gilead Sciences, Inc.
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ